Objective: To examine and compare the effects of pregnancy on the thyroid hormone homeostasis in two different populations with variable iodine supply. Design: A longitudinal prospective cohort study throughout pregnancy involving Swedish and Sudanese pregnant women. Setting: The subjects were enrolled consecutively during their antenatal follow-up at health centres at Nyby in Uppsala, Sweden and Omdurman in Sudan. Subjects: Fifty-one apparently healthy women from Uppsala, Sweden and twenty-eight pregnant women from Omdurman, Sudan were recruited during pregnancy. The mean age and weight of the Swedish women at the beginning of pregnancy were 29.9 AE 5.4 y and 66.3 AE 12.9 kg respectively. The corresponding ®gures for the Sudanese women were 28.0 AE 4.9 y and 64.8 AE 9.4 kg respectively. Methods: Blood samples were drawn on four occasions from the Swedish group at 11±13, 24, 32, and 38 weeks of pregnancy, and on three occasions from the Sudanese group at 10±12, 20±24, and 36±39 weeks. Twenty-four hour urine samples were collected from the same subjects and on the same occasions as blood sampling. The urine samples were kept in a refrigerator until the volumes were measured, after which 20 mL aliquots were taken and kept frozen until analysed. No signi®cant changes in daily urinary iodine loss were observed in the two groups with progression of pregnancy. However, in the Swedish women the mean free T4 concentration fell from 11.81 pmol/l at the beginning of pregnancy to 8.82 pmol/l and the mean TSH rose from 1.11±1.95 mU/l between the beginning and end of pregnancy. Such changes were not detected among the Sudanese women, who had signi®cantly lower mean TSH values than the Swedish women in weeks 36±39 of pregnancy (P`0.02), and signi®cantly higher FT4 values than the Swedish women both in weeks 20±24 and in weeks 36±39 (P`0.005 and P`0.001) respectively. Conclusions: The study suggests that determination of urinary iodine alone gives inadequate information about the capacity of an individual to utilize an available iodine supply and it also shows the existence of different patterns of thyroid response during pregnancy. The history of iodine availability prior to and during pregnancy seems to be an important determinant of the mechanism of thyroid gland response to ensure the extra iodine needed by the growing fetus. Sponsorship: Financial support for this work was provided by the Swedish Medical Research Council and InDevelop AB, Uppsala University.
Introduction
Thyroid hormones are critical for early development in fetal life (Hetzel & Hay, 1979; Paroah et al, 1971; Thilly et al, 1978) . These hormones reach the fetus through placental transfer, as evidenced by the near-normal T4 levels in cord blood of children with congenital inability to synthesize thyroid hormone (Vulsma et al, 1989) . The fetal thyroid is capable of producing hormones from 11 weeks of gestation (Thorpe-Beeston et al, 1991) .
Marked changes in the maternal serum levels of thyroid hormones take place during pregnancy. Human chorionic gonadotrophin (HCG) produced by the placenta has a weak thyroid stimulatory effect and the rapid rise in HCG in early pregnancy is often accompanied by some alterations in serum thyroid hormone and thyrotropin (TSH) levels (Braunstein & Herhman, 1976; Yoshkawa et al, 1989; Pekonen et al, 1988) . Also, the marked increase in the synthesis of thyroxine-binding globulin resulting from the increasing oestrogen levels affects the thyroid hormone homeostasis by expanding the thyroid hormone binding compartment (Glinoer et al, 1990; Ericsson & Threll, 1986; Amino et al, 1981) . Further the extra need of iodine imposed by pregnancy can serve to unmask a mild iodine de®ciency as re¯ected in a relative hypothyroxinaemia and increasing maternal TSH levels (Glinoer et al, 1990) .
No detailed study of changes in thyroid hormone levels has been carried out on pregnant women in Sweden in recent years, a country where iodine supplementation of salt was introduced in the 1930s and the iodine intake is assumed to be suf®cient. The high frequency of goitre that was seen in certain areas of Sweden prior to salt iodisation has virtually disappeared (Sjo Èberg & Sundlo Èf, 1971) . In 1933 the Swedish health authority recommended that 10 mg of potassium iodide should be added to each kg of table salt. This recommendation was increased to 50 mg per kg in 1966. Today, the total intake of iodine per day is considered to be approximately 1.58 mmol, with a large part of this intake derived from milk and dairy products. Only limited systematic studies of iodine intake and excretion, however, have been conducted in modern times. The urinary iodine excretion was examined in 1974 in a study of 102 adults in a community in Eastern Sweden. The mean daily urinary iodine excretion among 38 males was 1.01 mmol and among females it was 0.75 mmol. Thirty percent of the women had values below 0.55 mmol while less than 10% of the males had levels below this value (Ja Èrnerot & Karlberg, 1974; Gustafsson et al, 1977; Sjo È-berg, 1972; Karlsson, 1993) .
In contrast, iodine de®ciency is still prevalent in many parts of Sudan and the goitre frequencies are high (Eltom, 1984) . Various measures to provide iodine have been undertaken. Iodine-containing capsules , iodine forti®cation of sugar and iodination of water (Elnagar et al, 1997) have been tried in de®ned areas of the country. In Khartoum, the goitre frequency among school children and the low urinary iodine output have indicated the presence of moderate iodine de®ciency (Eltom, 1984) .
The purpose of the present investigation was to examine and compare the effect of pregnancy on thyroid hormone homeostasis in Swedish and Sudanese women, by measurements of urinary iodine concentrations, thyroid hormone levels and TSH.
Subjects and methods
The Swedish women Fifty-one apparently healthy pregnant women from Uppsala, Sweden were enrolled at Nyby Health Centre, Uppsala, between July 1993 and March 1995. At their initial presentation at the Health Centre, the women gave their informed consent to take part in the study, which had ®rst been approved by the Ethical Committee of Uppsala University, Sweden. The mean age and weight of the women at the beginning of pregnancy were 29.9 AE 5.4 y (range 22±40) and 66.3 AE 12.9 kg (range 53±101), respectively. The women were recruited during the 11th and 13th weeks of pregnancy.
Nineteen subjects did not complete the study for personal reasons (n 8) or because of miscarriage (n 3), or change of residence (n 8). The analysis is thus based on 32 subjects who completed the sampling. Although no systematic dietary survey was carried out among the women, they were all known to consume ordinary Swedish food. In Sweden both iodinated (50 ppm) and noniodinated salt is available.
The Sudanese women Twenty-eight pregnant women from Omdurman, an urban area in Sudan were enrolled between September 1993 and March 1995. At their initial presentation at the Health Centres, the subjects gave their informed consent. The women were apparently healthy but lived in an area considered to represent mild to moderate iodine de®ciency.
However, none of those who consented to take part in the study had goitre. Their mean age and weight were 28.0 AE 4.9 y (range 20±35) and 64.8 AE 9.4 kg (range 45± 84), respectively. The women were recruited during the 10th and 12th weeks of pregnancy. Three subjects did not complete the study because of miscarriage (n 2), or because they were not available at the time of sampling (n 1). The analysis is thus based on 25 women, who completed the study. Iodination of salt is not yet established in Sudan.
Sample collections
Venous blood samples were collected from the Swedish and the Sudanese pregnant women at routine check-up visits to the antenatal clinics. Blood samples were drawn on four occasions from the Swedish group at 11±13, 24, 32, and 38 weeks of pregnancy, and on three occasions from the Sudanese group at 10±12, 20±24, and 36±39 weeks. Blood samples were taken from the cubital veins into acidresined vacutainers. Blood was allowed to coagulate at room temperature, before the sera were separated by centrifugation and kept at 720 C. Twenty-four-hour urine samples were collected from the same subjects and on the same occasion as blood sampling. The urine samples were kept in a refrigerator until the volumes were measured, after which 20 mL aliquots were taken and kept frozen until analysed. The deep-frozen samples from Sudan were transported by¯ight from Khartoum to Stockholm. On arrival the samples were kept frozen in a central store along with the Swedish samples at 720 C.
Analytical methods
Urine iodine concentrations were determined in both the Swedish and the Sudanese samples in duplicate by one and the same experienced laboratory technician in Uppsala, Sweden, by a modi®ed Sandell±Kolthoff method (Sandell & Kolthoff, 1935) , using a Hitachi U-2000 spectrophotometer (Tokyo, Japan). The coef®cient of variation for duplicate standard samples was less than 3%. The withinseries coef®cient of variation was less than 8% and the between-series variation was less than 10%. The conversion factor from SI units is 1 mmol/L 12.7 mg/dL. Serum triiodothyronine (T3) and free thyroxine (FT4) were measured with solid phase time-resolved¯uoroimmunoassays (TR-FIA) (Del®a TM , Wallac Oy, Turku, Finland). The reference range in Swedish adult non-pregnant subjects for T3 is 1.2±2.8 nmol/L and for FT4 9±21 pmol/L. TSH was measured with a sandwich TR-FIA (Del®a TM hTSH Ultra, Wallac Oy, Turku, Finland). The reference range in Swedish adult non-pregnant subjects is 0.3±4.0 mU/L. For eleven Sudanese samples we were unable to measure T3 and TSH values. In three of these we were also unable to measure FT4, because of lack of serum for these assays.
Statistical analysis
Basic statistical methods were used to reveal signi®cant differences between the groups, as well as over time, in the variables studied. Within the groups t-tests for dependent samples (paired t-test) were performed for time 1 (10±13 weeks) versus each of the successive times. Between the groups (countries) t-tests for independent samples (unpaired t-test) were used for all variables at all comparable times. Further analysis of variance (ANOVA) on each parameter was used and showed differences between the countries for urine volume, UIC and FT4 and differences over time for TSH and FT4. The changes in the 24 h urinary iodine loss in relation to weeks of pregnancy in both the Swedish and the Sudanese women are illustrated in Figure 1 . The mean 24 h urinary iodine loss for the Swedish subjects during follow-up ranged between 1.14 and 1.40 mmol/d, and for the Sudanese subjects between 0.29 and 0.56 mmol/d. Both the Swedish and the Sudanese subjects showed a relatively stable 24 h urinary iodine loss throughout pregnancy. However, the Swedish women had signi®cantly higher 24 h urinary iodine loss than the Sudanese women in all sampling occasions (P`0.001; P`0.001; and P`0.001).
The mean urinary iodine concentrations (UIC) values did not change with progression of pregnancy were found in either the Swedish or the Sudanese women. However, the Swedish women had signi®cantly higher UIC than the Sudanese women at all stages of pregnancy (P`0.001, P`0.001 and P`0.001). No Swedish subjects had UIC below 0.16 mmol/L (According to the WHO classi®cation (WHO/UNICEF/ICCIDD Indicators for Assessing Iodine De®ciency Disorders IDD). Document WHO/NUT/94.6), the percentages of subjects with urinary iodine concentrations of less than 0.39 and 0.79 mmol/L (namely 5 and 10 mg/dL) should be less than 20% and 50%, respectively, for the population to be regarded as iodine suf®cient. In earlier classi®cations 2 mg/dL (namely 0.16 mmol/L) was also employed as a discriminatory level), at any time during pregnancy, whereas 25%, 30% and 9% of the Sudanese women had UIC values below 0.16 mmol/L on the three measurement occasions, respectively (Table 1) .
The proportion of Swedish women with UIC less than 0.79 mmol/L increased from 60% in weeks 11±13 to 71% in week 38 of pregnancy, and that of Sudanese women from 86% in weeks 10±12 to 96% in 20±24 and 91% in weeks 36±39.
There was a signi®cant decrease in mean serum FT4 in the Swedish population between weeks 11±13 and all other sampling occasions (P`0.001; P`0.001; and P`0.001).
The percentages of subjects with FT4 values below the reference range for non-pregnant individuals increased throughout the follow-up from 2% in week 11±13 to 58% in week 24, 62% in week 32 and 55% in week 38 (Table 2) . No subject showed FT4 values above the reference range at any time during pregnancy (Figure 2) .
In contrast to the Swedish values, the Sudanese mean FT4 values showed no signi®cant changes during pregnancy. However, the number of subjects with FT4 values below the reference range varied from 23% in week 10±12 to 40% in week 20±24 and 14% in week 36±39. No subject showed FT4 values above the reference range. The Sudanese women had signi®cantly higher FT4 values than the Swedish women both in weeks 20±24 and in weeks 36±39 (P`0.005 and P`0.001).
The mean TSH values in the Swedish subjects increased Figure 1 Changes in 24 h urinary iodine output (mean and its 95% con®dence interval) in relation to weeks of pregnancy in the Swedish (d) and Sudanese (s) women, measured in 32 and 25 women, respectively. $, P`0.05, compared to values at 10±13 weeks. (***), P`0.001, compared to the Swedish group. Figure 2 Changes in serum thyroptropin (TSH; mean and its 95% con®dence interval) in relation to weeks of pregnancy in the Swedish (d) and Sundanese (s) women. w P`0.007, ww P`0.004, www P`0.001, compared to values at 10±13 weeks (*), P`0.02, compared to the Swedish group.
Thyroid function and pregnancy B Elnagar et al steadily throughout pregnancy ( Figure 3 ) and this increase was statistically signi®cant on all occasions in relation to the weeks 11±13 mean value (P`0.004; P`0.007 and P`0.001). No subject had a TSH value above the reference range at 11±13 weeks, while 3%, 0% and 7% had values above this range in weeks 24, 32 and 38, respectively. The percentages of subjects with TSH values of more than 4 mU/L during the study period are shown in Table 3 . In contrast to the values in Swedish women, the Sudanese values displayed a relatively stable pattern throughout pregnancy. No Sudanese subject had a TSH value above the reference range. The Swedish women had signi®cantly higher mean TSH values than the Sudanese women in weeks 36±39 of pregnancy (P`0.02). The mean value for T3 at the beginning of pregnancy in the Swedish women was 2.49 AE 0.66 nmol/L and the mean T3 values later in pregnancy remained constant at around 2.70 nmol/L. The Swedish subjects showed a stable pattern and there were no signi®cant differences between the values on the different sampling occasions. The mean T3 value at the beginning of pregnancy in the Sudanese women was 2.75 AE 0.98 nmol/L and the values later in pregnancy were 2.87 AE 0.76 and 2.57 AE 0.43 nmol/L, respectively. There were no signi®cant differences between Swedish and Sudanese groups.
Discussion
The urinary iodine excretion pattern observed in the present study illustrates that the two groups of women differed in their iodine status. The iodine outputs were lower throughout pregnancy among the Sudanese women than among the Swedish women, in accordance with previous reports of an increased goitre frequency among people living in Khartoum. In this present study the Swedish pregnant women had a somewhat higher urinary iodine output than Swedish non-pregnant adult individuals in a previous study (Sjo È-berg, 1972 ). This could be either due to higher iodine intake or due to the effects of pregnancy in these women. The Sudanese women consistently produced lower urinary volumes than their Swedish counterparts, presumably as a result of a lower water intake and a higher degree of perspiration. Twenty-four-hour urine volumes are admittedly dif®cult to obtain in a reliable and reproducible way. However, the observed distribution of volumes in the two groups contradicts a possibility of signi®cant methodological differences in urine sampling in Sweden and Sudan. Besides, the differences between the Swedish and the Sudanese women is maintained irrespective of whether urinary iodine concentration or 24 h urinary iodine loss are used in the comparison. The loss of iodine through extra-renal routes is reportedly minor. Thus, the concentration of iodine in sweat has been estimated at 0.29 AE 0.04 mmol/L (Mao et al, 1990) , and about 5% of the body's iodine loss occurs in the stools (Choufoer et al, 1963) . We therefore consider it likely that the Sudanese women had a lower iodine intake than the Swedish women. The differences between the two groups in loss of total iodine through sweat or faeces could only be small.
In many African countries with notable iodine de®-ciency, subjects may occasionally encounter iodine in their diet. The thyroidal economy is thus subjected to both iodine restriction and occasional iodine supply in a reproducible manner. Thus, such an irregular and sporadic iodine supply is unlikely to be re¯ected in iodine excretion levels. The little iodine available will mainly have been stored in the thyroid gland because of avid thyroidal iodine uptake. However, to the best of our knowledge no iodine supplementation of any kind was ongoing in the study area.
Several studies of thyroid hormone changes as well as of changes in thyroid volume during pregnancy have been carried out in Europe in recent years. In a series of illustrative investigations in Belgium (Glinoer et al, 1990; Glinoer et al, 1995) , it was shown that the FT4 levels tend to decrease and the TSH levels to increase, but remain within the reference ranges of non-pregnant individuals. Several reports indicate an increase in thyroid volume during pregnancy (Glinoer et al, 1990; Rasmussen et al, 1989; Glinoer et al, 1995) . Precise determinations of thyroid volume need thyroid ultrasonography. For practical reasons we were unable to monitor the thyroid volume in the present study. However, as stated above under Subjects, none of the Sudanese women who took part in the study had visible or palpable goiter. It is evident that we have, unknowingly selected women with a particularly ef®cient thyroidal machinery that is capable of handling available iodine in a manner that is different from the case of the average woman. This fact must be kept in mind when interpreting our data. Such extremely ef®cient thyroid glands are some of the explanations forwarded regarding why some subjects residing in severely iodine de®cient areas do not develop goiter.
We found an inverse relationship between TSH and FT4 values in the Swedish group. The mean free T4 levels fell from mid-pregnancy onwards, and the mean TSH levels rose. These changes con®rm earlier reports indicating that pregnancy is associated with a decrease in FT4 and an increase in TSH among mildly iodine-de®cient women (Glinoer et al, 1995) , and that pregnancy unmasks relative iodine-de®ciency. The Sudanese women did not show such Figure 3 Changes in serum free thyroxine (FT4; mean and its 95% con®dence interval) in relation to weeks of pregnancy in the Swedish (d) and Sudanese (s) women. www P`0.001, compared to values at 10±13 weeks. (**) P`0.005, (***) P`0.001 compared to the Swedish group. changes, probably because of thyroid gland adaptation through an increased volume and an enhanced capacity to absorb iodine by the thyroid, gut or kidneys or to mobilise stores. The response among the Sudanese women con®rms the pattern of changes observed in moderate iodine de®-ciency during pregnancy (Silva & Silva, 1981) . Although the mean urinary iodine output in the Swedish group was signi®cantly higher than in the Sudanese group, the Swedish women, on the average, had lower FT4 levels than the Sudanese group in weeks 20±24 and 36±39. Furthermore, the mean TSH value in weeks 36±39 was signi®cantly higher in the Swedish women than in the Sudanese. The effects of administration of iodine to pregnant women have been studied in a number of iodine-de®cient areas (Glinoer et al, 1995; Romano et al, 1991; Pederson et al, 1993) . In general such iodine supply leads to stabilisation of serum TSH, and a signi®cant reduction in the increase in thyroid size, while no marked change in FT4 is produced. Administration of iodine combined with Lthyroxine (Glinoer et al, 1995) has been found to improve all thyroid function parameters. Glinoer (Glinoer et al, 1995) have suggested that goitre in pregnancy without iodine de®ciency should be treated with L-thyroxine, and goitre in the presence of iodine de®ciency with iodine supplementation alone. A question may be raised concerning the need for supplmentation of pregnant women living in an area with mild iodine de®ciency: Should thyroxine or iodine only, or iodine combined with thyroxine, be given? The alterations in thyroid-related hormones and urinary iodine output observed among the Swedish group might raise a question of iodine supplementation. However, further studies involving a larger sample on thyroid function based on biochemical markers such as T3/T4 ratios, serum thyroglobulin as well as changes in thyroid volume on thyroid function during pregnancy are needed in both Sweden and Sudan. Such studies could also investigate the effects of iodine supply on these populations as well as their newborns. The history of iodine availability prior to and during pregnancy seems to be an important determinant of the mechanism of thyroid gland response to ensure the extra iodine needed by the growing fetus. Therefore, the study of the effects of correction of mild or moderate iodine de®ciency on the overall thyroid function during pregnancy would be of particular interest.
Conclusions
Our data suggests that determination of urinary iodine alone gives inadequate information about the capacity of an individual to utilize an available iodine supply. This study also shows the existence of different patterns of thyroid response during pregnancy.
